U.S. market Closed. Opens in 4 hours 11 minutes

ZIVO | ZIVO Bioscience, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 20.75 - 21.00
52 Week Range 0.4800 - 22.15
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 270
Average Volume 1,831
Shares Outstanding 3,535,130
Market Cap 74,096,325
Sector Healthcare
Industry Biotechnology
IPO Date 2003-12-15
Valuation
Profitability
Growth
Health
P/E Ratio -3.93
Forward P/E Ratio N/A
EPS -5.33
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 8
Country USA
Website ZIVO
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan.
*Chart delayed
Analyzing fundamentals for ZIVO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see ZIVO Fundamentals page.

Watching at ZIVO technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ZIVO Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙